Opus Genetics, Inc. (IRD) stock
IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.05+0.01 (+0.25%)
Close on Nov 17, 2026Market cap $336.94MP/E –Yield –
Opus Genetics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Opus Genetics's revenue for the twelve months ending Jun 30, 2026 was $9.86M, down 36.1% year over year. For fiscal 2025 it was $14.20M, up 29.1% from the year before. The highest annual figure on record is $39.85M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.20M | +29.1% |
| FY2024 | Dec 31, 2024 | $10.99M | -42.3% |
| FY2023 | Dec 31, 2023 | $19.05M | -52.2% |
| FY2022 | Dec 31, 2022 | $39.85M | +6665.7% |
| FY2021 | Dec 31, 2021 | $589.00K | – |
| FY2020 | Dec 31, 2020 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $3.00M | – |
| FY2013 | Dec 31, 2013 | $0 | – |
| FY2012 | Dec 31, 2012 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | – |
| FY2010 | Dec 31, 2010 | $0 | – |
| FY2009 | Dec 31, 2009 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $755.00K | -73.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.16M | -50.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.87M | -10.2% |
| Q3 FY2025 | Sep 30, 2025 | $3.08M | -20.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.88M | +159.2% |
| Q1 FY2025 | Mar 31, 2025 | $4.37M | +155.4% |
| Q4 FY2024 | Dec 31, 2024 | $4.30M | +154.4% |
| Q3 FY2024 | Sep 30, 2024 | $3.87M | -67.6% |
| Q2 FY2024 | Jun 30, 2024 | $1.11M | -69.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.71M | -2.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.69M | -95.8% |
| Q3 FY2023 | Sep 30, 2023 | $11.94M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.67M | – |
| Q1 FY2023 | Mar 31, 2023 | $1.75M | – |
| Q4 FY2022 | Dec 31, 2022 | $39.85M | – |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $489.00K | – |
| Q2 FY2021 | Jun 30, 2021 | $100.00K | -91.3% |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $1.15M | -61.7% |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $3.00M | – |
See a number that looks wrong?